ISRCTN70010120已完成不适用
Does aldosterone blockade improve endothelial dysfunction in patients with coronary artery disease but without heart failure?
niversity of Dundee (UK)0 个研究点目标入组 88 人开始时间: 2006年3月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patient with known coronary artery disease
- •2. Chronic stable angina
排除标准
- •1. Left ventricular systolic dysfunction
- •2. Renal failure
- •3. Hyperkalaemia
- •4. Warfarin therapy
研究者
相似试验
已完成
3 期
Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)ADPKDNCT01853553University of Colorado, Denver61
尚未招募
4 期
se of aldosterone blockade to improve cardiac function in obesityDiastolic DysfunctionMyocardial fibrosisCardiovascular - Other cardiovascular diseasesACTRN12609000655246The University of Queensland120
已完成
不适用
Effects of aldosterone antagonism on microvascular function in obese individualsNL-OMON45212niversiteit Maastricht60
已完成
不适用
Aldosterone-induced microvascular dysfunction as a cause of salt-sensitivity in obesity?insulin resistance/decreased sensitivity for insulinsalt-sensitivity of blood pressure1001842410057166NL-OMON40283Medisch Universitair Ziekenhuis Maastricht40
招募中
3 期
Evaluation of spironolactone on heart related mortality and morbidity among patients undergoing chronic kidney dialysisCTRI/2019/06/019703Population Health Research Institute